19 June 2013
Keywords: Mild stroke, Tissue plasminogen activator, Clot-busting drug, Savings
Article | 11 February 2011
Treating mild strokes with the clot-busting drug approved for severe stroke could reduce the number of patients left disabled and ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
11 February 2011
10 February 2011
18 June 2013
© 2013 thepharmaletter.com